Emerging role of donor-specific anti–human leukocyte antigen antibody determination for clinical management after solid organ transplantation
Authors:
- Adriana ZeeviAZAdriana Zeevi
- John G. LunzJLJohn G. Lunz
- Ron ShapiroRSRon Shapiro
- Parmjeet RandhawaPRParmjeet Randhawa
- George MazariegosGMGeorge Mazariegos
- Steven WebberSWSteven Webber
- Alin GirnitaAGAlin Girnita
- 1 August 2009
- journal article
- Published by Elsevier in Human Immunology
- Vol. 70 (8) , 645-650
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pediatric Intestinal Retransplantation: Techniques, Management, and OutcomesTransplantation, 2008
- Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantationTransplant Immunology, 2008
- Detecting and monitoring human leukocyte antigen–specific antibodiesHuman Immunology, 2008
- Antirejection Treatment in Kidney Transplant Patients with BK ViruriaTransplantation, 2008
- Alemtuzumab Preconditioning With Tacrolimus Monotherapy—The Impact of Serial Monitoring for Donor-Specific AntibodyTransplantation, 2008
- HLAMatchmaker: A Molecularly Based Algorithm for Histocompatibility Determination. V. Eplet Matching for HLA-DR, HLA-DQ, and HLA-DPHuman Immunology, 2007
- Anti‐HLA alloantibodies in pediatric solid organ transplantationPediatric Transplantation, 2006
- C4d deposition in lung allografts is associated with circulating anti-HLA alloantibodyTransplant Immunology, 2005
- Impact of ELISA-Detected Anti-HLA Antibodies on Pediatric Cardiac Allograft OutcomeHuman Immunology, 2005
- Anti-HLA antibody analysis and crossmatching in heart and lung transplantationTransplant Immunology, 2004